Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUT8 | Q9BYC5 | 1/20 | 0.44 |
| ▸ | CHAT | P28329 | 3/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | APEX1 | P27695 | 2/20 | 0.40 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.39 |
| ▸ | P2RY2 | P41231 | 4/20 | 0.37 |
| ▸ | P2RY12 | Q9H244 | 4/20 | 0.37 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.37 |
| ▸ | P2RX2 | Q9UBL9 | 2/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 4/20 | 0.37 |
| ▸ | CA1 | P00915 | 4/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | CA9 | Q16790 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20314643 | 0.93 | FUT8 (0.43) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL3653222 | 0.88 | FUT8 (0.46) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL4167795 | 0.88 | FUT8 (0.46) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL29637596 | 0.88 | FUT8 (0.46) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL12954926 | 0.84 | FUT8 (0.43) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL9270771 | 0.82 | FUT8 (0.48) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL9740928 | 0.82 | FUT8 (0.48) | FUT8CHATUSP2APEX1HPGDS | |
| SCHEMBL3655409 | 0.81 | CARM1 (0.42) | FUT8USP2APEX1P2RY2P2RY12 | |
| SCHEMBL29575012 | 0.81 | CARM1 (0.42) | FUT8USP2APEX1P2RY2P2RY12 | |
| SCHEMBL20314644 | 0.80 | FUT8 (0.42) | FUT8CHATUSP2APEX1HPGDS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403987-B2 | Charged particles | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| US-20120229884-A1 | CHARGED PARTICLES | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120229884-A1 | CHARGED PARTICLES | POLE3, POLD3, IPO4 | FUT8 769/4885CHAT 1302/4885USP2 3518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.